Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Virginia Escamilla

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 29, 2018
Allocation to Matched Related or Unrelated Donor Results in Similar Clinical Outcomes without Increased Risk of Failure to Proceed to Transplant among Patients with Acute Myeloid Leukemia: A Retrospective Analysis from the Time of Transplant ApprovalEduardo Rodríguez-Arbolí, Francisco José Márquez-Malaver, Nancy Rodríguez-Torres, et al.
Journal of Translational Medicine|August 19, 2025
Unveiling the influence of CAR-negative T-cells: enhancing efficacy and ensuring safety in CAR-T therapiesBelén Sierro-Martínez, Beatriz Guijarro-Albaladejo, Ricardo Fernández-Cisnal, et al.
Scientific Reports|May 19, 2022
Combined treatment of graft versus host disease using donor regulatory T cells and ruxolitinibAlfonso Rodríguez-Gil, Virginia Escamilla-Gómez, Melanie Nufer, et al.
Cellular Oncology (Dordrecht, Netherlands)|August 27, 2024
Next-generation BCMA-targeted chimeric antigen receptor CARTemis-1: the impact of manufacturing procedure on CAR T-cell featuresBelén Sierro-Martínez, Virginia Escamilla-Gómez, Laura Pérez-Ortega, et al.
Blood Advances|July 30, 2025
Ixazomib decreases the risk of chronic graft-versus-host disease: identification of cGvHD biomarkersTeresa Caballero-Velázquez, Javier Delgado-Serrano, Lucia López-Corral, et al.
Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research|December 20, 2019
Circulating microRNA after autologous bone marrow mononuclear cell (BM-MNC) injection in patients with ischemic strokeFernando Mancha, Irene Escudero-Martinez, Elena Zapata-Arriaza, et al.
Journal of Translational Medicine|July 11, 2026
Metabolic and functional analysis including repetitive antigen stimulation provides a more accurate assessment for CAR-T cell product quality and long-term functionalityBeatriz Guijarro-Albaladejo, Belén Sierro-Martínez, Inmaculada Carrasco-Brocal, et al.
Stroke|April 30, 2025
Diffusion Tensor Imaging Study After Intraarterial Cell Therapy in Acute Ischemic Stroke: A Substudy of the IBIS Randomized Clinical TrialJuan Antonio Cabezas-Rodriguez, Carles Biarnes, Marian Martí-Navas, et al.
The Lancet. Neurology|January 21, 2023
Safety and efficacy of intra-arterial bone marrow mononuclear cell transplantation in patients with acute ischaemic stroke in Spain (IBIS trial): a phase 2, randomised, open-label, standard-of-care controlled, multicentre trialFrancisco Moniche, Juan Antonio Cabezas-Rodriguez, Roberto Valverde, et al.
Bone Marrow Transplantation|December 11, 2024
Ruxolitinib in acute and chronic graft-versus-host disease: real life long-term experience in a multi-center study for adult and pediatric patients, on behalf of the GETH-TCVirginia Escamilla-Gómez, Valentín García Gutiérrez, Patricia Alcalde-Mellado, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 29, 2018
Allocation to Matched Related or Unrelated Donor Results in Similar Clinical Outcomes without Increased Risk of Failure to Proceed to Transplant among Patients with Acute Myeloid Leukemia: A Retrospective Analysis from the Time of Transplant ApprovalEduardo Rodríguez-Arbolí, Francisco José Márquez-Malaver, Nancy Rodríguez-Torres, et al.
Journal of Translational Medicine|August 19, 2025
Unveiling the influence of CAR-negative T-cells: enhancing efficacy and ensuring safety in CAR-T therapiesBelén Sierro-Martínez, Beatriz Guijarro-Albaladejo, Ricardo Fernández-Cisnal, et al.
Scientific Reports|May 19, 2022
Combined treatment of graft versus host disease using donor regulatory T cells and ruxolitinibAlfonso Rodríguez-Gil, Virginia Escamilla-Gómez, Melanie Nufer, et al.
Cellular Oncology (Dordrecht, Netherlands)|August 27, 2024
Next-generation BCMA-targeted chimeric antigen receptor CARTemis-1: the impact of manufacturing procedure on CAR T-cell featuresBelén Sierro-Martínez, Virginia Escamilla-Gómez, Laura Pérez-Ortega, et al.
Blood Advances|July 30, 2025
Ixazomib decreases the risk of chronic graft-versus-host disease: identification of cGvHD biomarkersTeresa Caballero-Velázquez, Javier Delgado-Serrano, Lucia López-Corral, et al.
Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research|December 20, 2019
Circulating microRNA after autologous bone marrow mononuclear cell (BM-MNC) injection in patients with ischemic strokeFernando Mancha, Irene Escudero-Martinez, Elena Zapata-Arriaza, et al.
Journal of Translational Medicine|July 11, 2026
Metabolic and functional analysis including repetitive antigen stimulation provides a more accurate assessment for CAR-T cell product quality and long-term functionalityBeatriz Guijarro-Albaladejo, Belén Sierro-Martínez, Inmaculada Carrasco-Brocal, et al.
Stroke|April 30, 2025
Diffusion Tensor Imaging Study After Intraarterial Cell Therapy in Acute Ischemic Stroke: A Substudy of the IBIS Randomized Clinical TrialJuan Antonio Cabezas-Rodriguez, Carles Biarnes, Marian Martí-Navas, et al.
The Lancet. Neurology|January 21, 2023
Safety and efficacy of intra-arterial bone marrow mononuclear cell transplantation in patients with acute ischaemic stroke in Spain (IBIS trial): a phase 2, randomised, open-label, standard-of-care controlled, multicentre trialFrancisco Moniche, Juan Antonio Cabezas-Rodriguez, Roberto Valverde, et al.
Bone Marrow Transplantation|December 11, 2024
Ruxolitinib in acute and chronic graft-versus-host disease: real life long-term experience in a multi-center study for adult and pediatric patients, on behalf of the GETH-TCVirginia Escamilla-Gómez, Valentín García Gutiérrez, Patricia Alcalde-Mellado, et al.
Pageof 2